Altimmune (ALT) Price to Sales (2017 - 2025)
Altimmune's (ALT) Price to Sales came in at 7757.46 for Q4 2025, down 70.3% from 26083.15 a year earlier and down 57.0% from the prior quarter.
Analysis
Altimmune (ALT) Price to Sales (2017 - 2025) Analysis & Trends
Since Q2 2017, Altimmune has reported Price to Sales for 35 quarters.
- In prior years, Altimmune's Price to Sales was 26083.15 in FY2024, 1406.17 in FY2023 (-88.2%), 11902.02 in FY2022 and 85.15 in FY2021 (+141.0%).
- The Q4 2025 figure stands as the lowest quarterly Price to Sales since Q2 2024.
- On a year-over-year basis, Price to Sales increased in 1 of the last four quarters, with an average decline of 18.3%.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q1 2021, with growth of 714.4%; the weakest was Q4 2023, with a decline of 88.2%.
- According to Business Quant data, Price to Sales for the three prior quarters was 18020.35 (Q3 2025), 16462.26 (Q2 2025) and 19456.36 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Altimmune | 536.75 Mn | 536.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7,757.46 |
| Sep 30, 2025 | 18,020.35 |
| Jun 30, 2025 | 16,462.26 |
| Mar 31, 2025 | 19,456.36 |
| Dec 31, 2024 | 26,083.15 |
| Sep 30, 2024 | 8,398.15 |
| Jun 30, 2024 | 1,155.15 |
| Mar 31, 2024 | 1,760.37 |
| Dec 31, 2023 | 1,406.17 |
| Sep 30, 2023 | 331.16 |
| Jun 30, 2023 | 3,379.66 |
| Mar 31, 2023 | 3,648.95 |
| Dec 31, 2022 | 11,902.02 |
| Sep 30, 2022 | 189.15 |
| Jun 30, 2022 | 156.13 |
| Mar 31, 2022 | 73.03 |
| Dec 31, 2021 | 85.15 |
| Sep 30, 2021 | 130.32 |
| Jun 30, 2021 | 62.80 |
| Mar 31, 2021 | 79.38 |
API Access
Altimmune Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();